Bogdana Balas
- Pulmonary and Respiratory Medicine top 0.5%
- Oncology top 1%
- Molecular Biology top 10%
- Cancer Research top 2%
- Pathology and Forensic Medicine top 5%
- Co-authors
- Ali ZeaiterSai‐Hong Ignatius OuAlice T. ShawShirish M. GadgeelD. Ross CamidgePeter N. MorcosJin Seok AhnSolange Peters
- Topics
- Lung Cancer Treatments and Mutations (23 papers)Lung Cancer Research Studies (13 papers)Lung Cancer Diagnosis and Treatment (8 papers)
- Partner nations
- SwitzerlandUnited StatesFrance
In The Last Decade
Bogdana Balas
26 papers receiving 3.2k citations
Hit Papers
Peers
Comparison fields: 5 of 88
- Pulmonary and Respiratory Medicine 2.8k
- Oncology 2.3k
- Molecular Biology 858
- Cancer Research 679
- Pathology and Forensic Medicine 249
Countries citing papers authored by Bogdana Balas
This map shows the geographic impact of Bogdana Balas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bogdana Balas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bogdana Balas more than expected).
Fields of papers citing papers by Bogdana Balas
This network shows the impact of papers produced by Bogdana Balas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bogdana Balas. The network helps show where Bogdana Balas may publish in the future.
Co-authorship network of co-authors of Bogdana Balas
This figure shows the co-authorship network connecting the top 25 collaborators of Bogdana Balas. A scholar is included among the top collaborators of Bogdana Balas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bogdana Balas. Bogdana Balas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 5 | |
| 2 | 8 | |
| 3 | 27 | |
| 4 | 21 | |
| 5 | Updated Efficacy and Safety Data and Impact of the EML4-ALK Fusion Variant on the Efficacy of Alectinib in Untreated ALK-Positive Advanced Non–Small Cell Lung Cancer in the Global Phase III ALEX Studybreakdown → | 319 |
| 6 | 24 | |
| 7 | 5 | |
| 8 | 10 | |
| 9 | 65 | |
| 10 | 33 | |
| 11 | Alectinib versus Crizotinib in Untreated ALK-Positive Non–Small-Cell Lung Cancerbreakdown → | 1619 |
| 12 | 5 | |
| 13 | 5 | |
| 14 | 18 | |
| 15 | 15 | |
| 16 | 3 | |
| 17 | Alectinib in ALK-positive, crizotinib-resistant, non-small-cell lung cancer: a single-group, multicentre, phase 2 trialbreakdown → | 462 |
| 18 | Alectinib in Crizotinib-Refractory ALK-Rearranged Non–Small-Cell Lung Cancer: A Phase II Global Studybreakdown → | 430 |
| 19 | 24 | |
| 20 | 62 |
About Bogdana Balas
Bogdana Balas is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research, having authored 26 papers that have together received 3.3k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (23 papers), Lung Cancer Research Studies (13 papers) and Lung Cancer Diagnosis and Treatment (8 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (2.8k citations), Oncology (2.3k citations) and Cancer Research (679 citations). Bogdana Balas has collaborated with scholars based in Switzerland, United States and France. Frequent co-authors include Ali Zeaiter, Sai‐Hong Ignatius Ou, Alice T. Shaw, Shirish M. Gadgeel, D. Ross Camidge, Peter N. Morcos, Jin Seok Ahn, Solange Peters, Tony Mok and Johannes Noé. Their work appears in journals such as New England Journal of Medicine, Journal of Clinical Oncology and The Lancet Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.